Evidence map›Paper›PMID 35289649›Full record

ArticleMicrobiology resource announcements2022

Draft Genome Sequences of Sixteen Fluoroquinolone-Resistant Extraintestinal Escherichia coli Isolates from Human Patients.

Khulud Alotaibi, Ashraf A Khan, Bernard Marasa, Saeed A Khan, James Johnson, Brian Johnston, Kidon Sung, Mohamed Nawaz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology resource announcements, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Comprehensive Genomic Analysis of UropathogenicPathogens (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Khulud AlotaibiU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA.
Ashraf A KhanU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA.
Bernard MarasaCenter for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Saeed A KhanU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA.ORCID 0000-0003-3473-8815
James JohnsonMinneapolis Veteran Administration Healthcare System, Minneapolis, Minnesota, USA.ORCID 0000-0002-9588-5045
Brian JohnstonMinneapolis Veteran Administration Healthcare System, Minneapolis, Minnesota, USA.ORCID 0000-0001-7347-9276
Kidon SungU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA.ORCID 0000-0002-7926-6156
Mohamed NawazU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA.

Funding

HHS | U.S. Food and Drug Administration (FDA) E0766201
6 · The paper itself

Abstract

We report here the draft genome sequences of 16 fluoroquinolone-resistant extraintestinal Escherichia coli isolates from human patients. These isolates had high MICs (32 to 256 μg/mL) for ciprofloxacin and contained point mutations in the quinolone resistance-determining region (QRDR) of both

Identifiers

PMID35289649
PMCPMC9022563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.